US › Healthcare

PACS Group, Inc. (PACS)

US · Healthcare · Medical Care Facilities

$44.81+0.70%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.42B
Revenue YoY
+11.2%
Net profit
$80.7M
Profit YoY
+183.4%
EPS
$0.64
EPS estimate
$0.41
Net margin
5.7%

EPS came in at 0.64 against a street estimate of 0.41 — a beat of 56.1%.

Key statistics

Market cap
$7.04B
P/E
28.7
Forward P/E
20.3
P/B
7.02
Book value
$6.60
EPS (TTM)
$1.55
52-week high
$48.00
52-week low
$7.50
50-day MA
$40.83
200-day MA
$33.75
Beta
-0.08

Analyst view

Analysts rate PACS Group, Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $52.67.

Shareholding

Insiders
69.53%
Institutions
30.81%

Largest institutional holders

FundStake
Cohen & Steers Inc5.76%
FMR Inc3.32%
Vanguard Group Inc2.85%
BlackRock Inc2.39%
Alyeska Investment Group, L.P.1.90%
Crewe Advisors LLC1.74%
Vanguard Portfolio Management, LLC1.18%
American Century Companies Inc1.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for PACS Group, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.